GLP-1 RA use in type 1 diabetes has been associated with an increased risk of symptomatic and asymptomatic hypoglycaemia [45]
Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on treg cell differentiation
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content
Complementary contributing factors encompass genetic predisposition, dysregulated inflammatory pathways, and metabolic comorbidities, which collectively modulate disease expression and progression (Dumusc and So, 2024)
Prog Neurobiol 1999, 58: 31-59